Plan to limit Medicare coverage for Alzheimer’s drug Aduhelm draws criticism
The proposal by the Centers for Medicare and Medicaid Services (CMS) to limit coverage for the Alzheimer’s drug Aduhelm to patients in clinical trials […]
Plan to limit Medicare coverage for Alzheimer’s drug Aduhelm draws criticism Read More »